NATUREX : Number of shares and voting rights as at 31 January 2018

NATUREX : Number of shares and voting rights as at 31 January 2018

Number of shares and voting rights

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)

Press release

Avignon, February 7, 2018

Total number of outstanding shares forming the capital

- 9,548,741 ordinary shares under ISIN FR0000054694

- 9,440 issued from stock-options under ISIN FR0000054694
9,558,181


Number of shares with double voting rights
 3,146,860


Total number of gross voting rights
12,705,041


Number of shares without voting rights

- 5,906 bearer shares in the frame of the liquidity contract
- 5,906


Total number of exercisable voting rights*
12,699,135

*Real number of voting rights = total number of voting rights – number of shares without voting rights

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.fr

2017 annual results
28 March 2018

- Analysts meeting (SFAF - French Society of

Financial Analysts), Paris
29 March 2018


- AGM, Avignon
21 June 2018

About Naturex

Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.

The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.

Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group employs 1,700 people worldwide and in 2017 had revenue of €405 million.

The Group is listed on Euronext Paris, Compartment B – Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY

NATUREX, From Nature to You

> Contact investors / financial media

Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

c.alexandre@naturex.com

Source: Actusnews